The Situation
Our client was preparing to bring a new treatment to market for an emergency condition treated in the hospital setting. They sought to better understand the product’s pricing potential, how it would be reimbursed in the hospital, and how payers and purchasers would react to its price.
The Solution
EVERSANA MANAGEMENT CONSULTING offered a truly unique solution to address our client’s need. Leveraging our broader EVERSANA capabilities, EVERSANA MANAGEMENT CONSULTING worked in parallel with our in-house HEOR experts to determine the current cost of care for the condition. We then calculated how costs would be lowered given the use of the new treatment – due to fewer hospital days, lower risk of expensive side effects, and so on.
With this information in hand, EVERSANA MANAGEMENT CONSULTING conducted extensive primary research with the target physicians that would be prescribing this therapy to gauge the perceived clinical value of the product. These interviews further supported the development of a budget impact model, a tool which we then provided to payers to demonstrate the cost savings the product could achieve on their plans – at a higher price point than initially anticipated.
